- JP-listed companies
- Oncolys BioPharma Inc.
- Balance sheet
Oncolys BioPharma Inc.【JP:4588】Balance sheet
Market cap
¥37.9B
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | - | 4,727 | 3,605 | 2,564 | 2,868 | 2,463 | 3,343 | 2,068 | 3,455 | 1,711 | 1,533 | 2,411 |
| Total current assets | - | 4,885 | 3,674 | 2,747 | 3,072 | 2,618 | 3,826 | 2,546 | 4,198 | 2,609 | 1,956 | 3,098 |
| Property, plant and equipment, net | - | 59 | 46 | - | 3 | 2 | 12 | 21 | - | - | - | - |
| Marketable securities, non-current | - | 25 | 248 | 352 | 400 | 668 | 329 | 0 | - | - | - | - |
| Total non-current assets | - | 124 | 332 | 394 | 455 | 812 | 554 | 251 | 94 | 42 | 85 | 101 |
| Total assets | - | 5,009 | 4,006 | 3,140 | 3,526 | 3,430 | 4,380 | 2,796 | 4,292 | 2,651 | 2,041 | 3,199 |
| Short-term debt | - | 173 | 93 | 63 | 93 | 83 | 128 | 150 | 239 | 228 | 128 | 128 |
| Total current liabilities | - | 263 | 177 | 205 | 239 | 212 | 524 | 415 | 430 | 322 | 379 | 252 |
| Long-term debt, non-current | - | 337 | 303 | 300 | 344 | 311 | 389 | 367 | 256 | 156 | 161 | 167 |
| Total non-current liabilities | - | 374 | 328 | 318 | 355 | 317 | 402 | 378 | 268 | 170 | 188 | 194 |
| Total liabilities | - | 637 | 504 | 523 | 594 | 529 | 926 | 793 | 698 | 492 | 567 | 447 |
| Common stock and paid-in capital | - | 10,137 | 10,137 | 10,174 | 11,597 | 12,798 | 14,245 | 14,897 | 18,103 | 3,586 | 4,833 | 7,803 |
| Retained earnings | - | -5,781 | -6,638 | -7,569 | -8,660 | -9,894 | -10,806 | -12,901 | -14,517 | -1,435 | -3,373 | -5,058 |
| Stockholders' equity | 5,094 | 4,371 | 3,501 | 2,617 | 2,932 | 2,901 | 3,454 | 2,003 | 3,594 | 2,159 | 1,474 | 2,752 |